Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.6.6 is now shown, replacing Revision: v3.6.5. This signals a new build of the page rather than any substantive content change.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history now shows Revision: v3.6.5 instead of v3.6.4, indicating a small update to the study record history display/backend. The change does not modify study data or visible content beyond the version label.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page shows a new site revision: v3.6.4, replacing v3.6.3. This indicates a small update to the site's interface/backend.SummaryDifference0.1%

- Check56 days agoChange DetectedA new Study Status row has been added to the history, and a new version (51) was recorded on 2026-07-14. An older history entry dated 2026-04-22 was removed.SummaryDifference0.2%

- Check71 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, signifying a newer version of the page in the study history and likely minor maintenance updates.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the record history page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.